News
- Author:
- Patrice Wendling
Publish date: November 3, 2014
Key clinical point: Comparable 5-year survival rates call into question the need to classify small lung carcinomas as adenocarcinoma in situ vs. m...
News
- Author:
- Patrice Wendling
Publish date: November 2, 2014
Key clinical point: A vaccine to prevent invasive Staphylococcus aureus infections is in the early stages of testing.
Major finding: At day 29, al...
News
- Author:
- Patrice Wendling
Publish date: October 30, 2014
News
- Author:
- Patrice Wendling
Publish date: October 29, 2014
Key clinical point: The overall incidence of community acquired CDI is increasing, with the rate of change highest among children.
Major finding: ...
News
- Author:
- Patrice Wendling
Publish date: October 29, 2014
Key clinical point: The overall incidence of community acquired CDI is increasing, with the rate of change highest among children.
Major finding: ...
News
- Author:
- Patrice Wendling
Publish date: October 22, 2014
Key clinical point: Adjuvant lung cancer vaccination failed to improve disease-free survival in early-stage non–small cell lung cancer.
Majo...
Video
- Author:
- Patrice Wendling
Publish date: October 22, 2014
News
- Author:
- Patrice Wendling
Publish date: October 21, 2014
Key clinical point: A BRAF and MEK inhibitor combination has greater efficacy than a BRAF inhibitor alone in BRAF mutation–positive melanoma...
News
- Author:
- Patrice Wendling
Publish date: October 19, 2014
Key clinical point: Clostridium difficile recurrences are holding steady, but they are frequently associated with hospital admission and complicat...
News
- Author:
- Patrice Wendling
Publish date: October 15, 2014
News
- Author:
- Patrice Wendling
Publish date: October 9, 2014
Key clinical point: The trend in care for treating advanced melanoma will be moving PD-1 blockade up front in treatment with less reliance on chem...
News
- Author:
- Patrice Wendling
Publish date: October 8, 2014
Key clinical point: Pertuzumab, trastuzumab, and docetaxel chemotherapy is the new standard for first-line metastatic HER2-positive breast cancer....
News
- Author:
- Patrice Wendling
Publish date: October 7, 2014
Key clinical point: Rolapitant was significantly better than placebo in reducing chemotherapy-induced nausea and vomiting.
Major finding: Complete...
News
- Author:
- Patrice Wendling
Publish date: October 3, 2014
News
- Author:
- Patrice Wendling
Publish date: October 2, 2014
